Overview
Tandem Technology, a New York-based healthcare AI startup, is raising $100 million in a funding round led by Accel, nearing a valuation of $1 billion. The company, which has previously raised $137 million, aims to automate prescription processing in the U.S. healthcare system, addressing significant bottlenecks. Its tools are offered at no cost to providers and patients, with plans to enhance collaboration with biopharma companies for drug development. Investor interest in healthcare AI solutions is strong, although key performance metrics have not been disclosed.
Products
Loading...
Recent Deals
Investors: Accel
Tandem Technology, a New York-based healthcare AI startup, is raising $100 million in a funding round led by Accel, nearing a valuation of $1 billion. The company, which has previously raised $137 million, aims to automate prescription processing in the U.S. healthcare system, addressing significant bottlenecks. Its tools are offered at no cost to providers and patients, with plans to enhance collaboration with biopharma companies for drug development. Investor interest in healthcare AI solutions is strong, although key performance metrics have not been disclosed.